Approval · Notice of Compliance 37718 · 2026
AJOVY: Notice of Compliance 37718
Issued June 17, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37718
- Date
- June 17, 2026
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additional drug substance manufacturing site and scale-up of the drug substance manufacturing process
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AJOVY | Not yet assigned | — |
Medicinal ingredients
- FREMANEZUMAB 225 MG per 1.5ML
- FREMANEZUMAB 225 MG per SYR